NIO
NIO Inc.
NIO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
OCG
Oriental Culture Holding Ltd.
There isn't enough reported data to score OCG yet.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
OCG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
OCG's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
OCG PE Valuation
OCG has no meaningful PE right now: it lost money over the past year.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
OCG Forward outlook
There aren't enough analyst estimates for OCG to show an outlook.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO has the edge over OCG in the latest year-over-year earnings comparison.
OCG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$107.26 | +$11.54 |
| Q4 2024 | -$118.80 | +$435.60 |
| Q4 2023 | -$554.40 | -212% |
OCG has swung to a loss: it lost $107.26 per share over the past year, after a profit the year before.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over OCG in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
OCG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $1.9M | +203% |
| Q4 2024 | $622.7K | -61% |
| Q4 2023 | $1.6M | -91% |
| Q4 2022 | $17.8M | -53% |
| Q4 2021 | $37.6M | +116% |
| Q4 2020 | $17.4M | +212% |
| Q4 2019 | $5.6M | +4.6% |
OCG's revenue has slid since its 2021 peak: $2M last quarter, down 95% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -203% | -232 points |
| Q4 2024 | -513% | -523 points |
| Q4 2023 | -274% | -322 points |
| Q4 2022 | 15% | -66 points |
| Q4 2021 | 29% | -21 points |
| Q4 2020 | 9.4% | N/A |
| Q4 2019 | 48% | N/A |
| Q2 2019 | 80% | N/A |
OCG's operating margin was −203% last quarter, down 232 points from the same quarter a year ago.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
OCG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$4.1M | -218% |
| Q4 2023 | $3.4M | +$5.4M |
| Q4 2022 | -$1.9M | -$1.3M |
| Q4 2021 | -$573.5K | -107% |
| Q4 2020 | $8.1M | +302% |
| Q4 2019 | $2M | -36% |
| Q2 2019 | $7.3M | +9184% |
| Q4 2018 | $3.1M | +7928% |
OCG's free cash flow has turned negative after years in the green: −$3M over the past year.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has the edge over OCG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
OCG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +79% | +15.9K shares |
| 1 year | +479% | +29.8K shares |
OCG has 35,968 diluted shares, up 479% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
| Q2 2019 | — |
| Q4 2018 | $125 |
| Q2 2018 | — |
| Q4 2017 | — |
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OCG Net Leverage
OCG's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
OCG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.6 | Oversold |
| Stochastic | 30.4 | Neutral |
OCG's weekly RSI is 25 (oversold) and its Stochastic is 30 (neutral).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
OCG PE vs Consumer Cyclical Sector
| Metric | OCG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
OCG has no meaningful PE right now: it lost money over the past year.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
OCG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.63 | 0.6% below |
| 20 week MA | $1.64 | 1.2% below |
| 50 week MA | $46.0 | 96% below |
| 100 week MA | $1,165.0 | 100% below |
| 200 week MA | $1,218.6 | 100% below |
OCG is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO has the edge over OCG on returns for 2026, with the stronger performance.
OCG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19,800.0 | $17,886.0 | -9.7% |
| 2021 | $17,886.0 | $16,632.0 | -7% |
| 2022 | $16,632.0 | $1,881.0 | -89% |
| 2023 | $1,881.0 | $943.8 | -50% |
| 2024 | $943.8 | $772.2 | -18% |
| 2025 | $772.2 | $56.8 | -93% |
| 2026 YTD | $56.8 | $1.62 | -97% |
OCG has finished every year since 2020 lower, and it's down 97% so far in 2026.